Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

29/09/2026

Farmacovigilanza attiva: Bando AIFA per un progetto nazionale dedicato a pazienti anziani, multicronici e in politerapia

Ultime notizie

01/06/2026

Sicurezza delle terapie avanzate per la malattia di Chron

Biblioteca Virtuale per la Salute – Piemonte

29/09/2026

Newsletter Promozione della Salute – Dors, settembre 2026

Agendas and minutes

29/09/2026

Agenda - Management Board meeting: 30 September 2026

Consumer Updates RSS Feed

15/09/2026

The Facts on Tampons and Tampon Safety

Regulatory and procedural guidelines (human and veterinary)

24/09/2026

Member states contact points for review of national implementation of quick response (QR) codes of veterinary medicinal products authorised via the centralised (CP), mutual recognition (MRP), decentralised procedures (DCP) and national procedures

Scientific guidelines (human and veterinary)

24/09/2026

Draft guideline on the clinical requirements for medicines intended for the treatment of sickle cell disease

Paediatric investigation plans

04/09/2026

Opinion/decision on a Paediatric investigation plan (PIP): Skyclarys, omaveloxolone, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Congenital, familial and genetic disorders, PIP number: EMA/PE/0000338563

New medicines and opinions: human

18/09/2026

Human medicines European public assessment report (EPAR): Adcomfo, omalizumab, Status: Opinion

MedWatch Safety Alerts RSS Feed

25/09/2026

Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters

What's New: Drugs RSS Feed

29/09/2026

Reviews of Pediatric Studies Conducted under BPCA and Pediatric assessments conducted under PREA from 2012 – present

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis